2020
DOI: 10.3390/cancers12123817
|View full text |Cite
|
Sign up to set email alerts
|

Machine Learning Algorithms to Predict Recurrence within 10 Years after Breast Cancer Surgery: A Prospective Cohort Study

Abstract: No studies have discussed machine learning algorithms to predict recurrence within 10 years after breast cancer surgery. This study purposed to compare the accuracy of forecasting models to predict recurrence within 10 years after breast cancer surgery and to identify significant predictors of recurrence. Registry data for breast cancer surgery patients were allocated to a training dataset (n = 798) for model development, a testing dataset (n = 171) for internal validation, and a validating dataset (n = 171) f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
32
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 41 publications
(33 citation statements)
references
References 33 publications
1
32
0
Order By: Relevance
“…The unit of statistical analysis in this Taiwanese study was the individual elderly patient [26,27]. Sample size calculations determined that, for a power of 0.80, a minimum sample of 120 study participants was needed with an alpha of 0.05 [28].…”
Section: Discussionmentioning
confidence: 99%
“…The unit of statistical analysis in this Taiwanese study was the individual elderly patient [26,27]. Sample size calculations determined that, for a power of 0.80, a minimum sample of 120 study participants was needed with an alpha of 0.05 [28].…”
Section: Discussionmentioning
confidence: 99%
“…The sigmoid was adopted as the final activation layer. This model was modified from a previous study in the medical fields [ 10 ].…”
Section: Methodsmentioning
confidence: 99%
“…Machine learning algorithms use large-scale clinical data and learn patterns to assess outcomes [ 10 ]. In the medical field, automatic prediction of cancer recurrence has been reported using artificial neural networks (ANNs) [ 10 , 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Novel techniques in AI can bring together diverse data types to expand novel insights gained from the multiomics datasets. It is well acknowledged that enrichment of high-quality data coupled with machine learning, a subset of AI, can help investigate the areas of changing patients’ unhealthy behaviors [ 22 ], risk prediction or recurrence prediction of chronic diseases after a surgery [ 23 ] and curative treatment [ 24 ], progression and survivability of patients with chronic diseases [ 25 ], therapeutic need, enhanced clinical trial interpretation, and novel targets [ 26 ]. However, a major criticism of incorporating AI, particularly deep learning, into medical fields is the idea that AI is essentially a mechanistically uninterpretable opaque “black box” [ 27 , 28 , 29 ], and hence may not meet the required high level of accountability, transparency, and reliability in medical decisions [ 30 ].…”
Section: Introductionmentioning
confidence: 99%